SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Galapagos Islands
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: plugger301 who wrote (36676)4/14/2003 4:11:51 PM
From: Jorj X Mckie  Read Replies (1) of 57110
 
16:12 ET IBM IBM misses by a penny, revs top consensus (80.07 halted)
Reports Q1 (Mar) earnings of $0.79 per share, $0.01 worse than the Multex consensus of $0.80; revenues rose 11.3% year/year to $20.07 bln vs the $19.86 bln consensus.

16:09 ET NVLS Novellus beats by a penny (27.37 +0.72)
Reports Q1 (Mar) earnings of $0.08 per share, $0.01 better than the Multex consensus of $0.07; revenues rose 9.6% year/year to $238.4 mln vs the $234.2 mln consensus.




16:08 ET IBM IBM headline number is $0.79, consensus $0.80 (80.07 halted) -- Update --
There is no press release available yet, so it isn't clear whether the numbers are comparable... more to follow.




16:07 ET RMBS Rambus reports in line with consensus estimates (15.67 +0.23)
Reports Q2 (Mar) earnings of $0.05 per share, in line with the Multex consensus of $0.05; revenues rose 19.4% year/year to $28.1 mln vs the $27.5 mln consensus.




16:06 ET CGNX Cognex reports in line, guides (18.85 +0.56)
Reports Q1 (Mar) earnings of $0.04 per share, in line with the Multex consensus of $0.04; revenues fell 2.8% year/year to $32.9 mln vs the $32.3 mln consensus. Co guides Q2 EPS of $0.05-0.07 vs Multex consensus of $0.06.




16:04 ET GSK GlaxoSmithKline announces positive Lamictal data (39.10 +1.01)
Co announces that results of a study show that Lamictal was effective in delaying the relapse/recurrence of any mood episode in bipolar I patients who had recently experienced and been treated for an acute manic or hypomanic episode; study results point to the therapeutic effects of Lamictal in the maintenance treatment of bipolar I disorder.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News